Related references
Note: Only part of the references are listed.PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival
Amanda R. Panfil et al.
VIRUSES-BASEL (2016)
Suppressive effects of tumor cell-derived 5 '-deoxy-5 '-methylthioadenosine on human T cells
Frederik C. Henrich et al.
ONCOIMMUNOLOGY (2016)
CCMCL1: a new model of aggressive mantle cell lymphoma
Xiaoxian Zhao et al.
BLOOD (2015)
Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation
Lapo Alinari et al.
BLOOD (2015)
The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
Nicole Stopa et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis
Cheryl M. Koh et al.
NATURE (2015)
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre et al.
NATURE CHEMICAL BIOLOGY (2015)
Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis
Yonghao Cao et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
PRMT9 is a Type II methyltransferase that methylates the splicing factor SAP145
Yanzhong Yang et al.
NATURE COMMUNICATIONS (2015)
PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers
Yan Li et al.
CANCER DISCOVERY (2015)
The signaling symphony: T cell receptor tunes cytokine-mediated T cell differentiation
Weishan Huang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma
Fengting Yan et al.
CANCER RESEARCH (2014)
Tumor Necrosis Factor (TNF)-α Induction of CXCL10 in Endothelial Cells Requires Protein Arginine Methyltransferase 5 (PRMT5)-mediated Nuclear Factor (NF)-κB p65 Methylation
Daniel P. Harris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro
Xiaosi Han et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Pathogenic memory type Th2 cells in allergic inflammation
Yusuke Endo et al.
TRENDS IN IMMUNOLOGY (2014)
Lupus autoimmunity altered by cellular methylation metabolism
Mei-Ling Yang et al.
AUTOIMMUNITY (2013)
Activation of PRMT1 and PRMT5 mediates hypoxia- and ischemia-induced apoptosis in human lung epithelial cells and the lung of miniature pigs: The role of p38 and JNK mitogen-activated protein kinases
Seul Ki Lim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors
Konstantin Shilo et al.
DIAGNOSTIC PATHOLOGY (2013)
Autoimmune effector memory T cells: the bad and the good
Priyadharshini Devarajan et al.
IMMUNOLOGIC RESEARCH (2013)
Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing
Jihyun Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Overexpression of PRMT5 Promotes Tumor Cell Growth and Is Associated with Poor Disease Prognosis in Epithelial Ovarian Cancer
Xiangxiang Bao et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2013)
Distinct TCR signaling pathways drive proliferation and cytokine production in T cells
Clifford S. Guy et al.
NATURE IMMUNOLOGY (2013)
PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB
Han Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Protein arginine methyltransferase 5 is essential for growth of lung cancer cells
Zhongping Gu et al.
BIOCHEMICAL JOURNAL (2012)
Arginine methylation controls growth regulation by E2F-1
Er-Chieh Cho et al.
EMBO JOURNAL (2012)
Human Protein Arginine Methyltransferase 7 (PRMT7) Is a Type III Enzyme Forming ω-NG-Monomethylated Arginine Residues
Cecilia I. Zurita-Lopez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility
Nicolas Couturier et al.
BRAIN (2011)
Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity
Mireia Guerau-de-Arellano et al.
BRAIN (2011)
Protein Arginine Methyltransferase 5 Accelerates Tumor Growth by Arginine Methylation of the Tumor Suppressor Programmed Cell Death 4
Matthew A. Powers et al.
CANCER RESEARCH (2011)
Increased Frequencies of Myelin Oligodendrocyte Glycoprotein/MHC Class II-Binding CD4 Cells in Patients with Multiple Sclerosis
Khadir Raddassi et al.
JOURNAL OF IMMUNOLOGY (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Versatility of PRMT5-induced methylation in growth control and development
Vrajesh Karkhanis et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Sp1/NFκB/HDAC/miR-29b Regulatory Network in KIT-Driven Myeloid Leukemia
Shujun Liu et al.
CANCER CELL (2010)
Effects of a novel arginine methyltransferase inhibitor on T-helper cell cytokine production
Kevin Bonham et al.
FEBS JOURNAL (2010)
Preclinical studies of methylthioadenosine for the treatment of multiple sclerosis
B. Moreno et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Kamran Ghoreschi et al.
NATURE (2010)
The TCR-mediated signaling pathways that control the direction of helper T cell differentiation
Toshinori Nakayama et al.
SEMINARS IN IMMUNOLOGY (2010)
Protein arginine methylation: a new handle on T lymphocytes?
Richard V. Parry et al.
TRENDS IN IMMUNOLOGY (2010)
T-bet is essential for encephalitogenicity of both Th1 and Th17 cells
Yuhong Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
PRMT5, a Novel TRAIL Receptor-Binding Protein, Inhibits TRAIL-Induced Apoptosis via Nuclear Factor-κB Activation
Hiroshi Tanaka et al.
MOLECULAR CANCER RESEARCH (2009)
Proteolysis of NF-kappa B1 p105 is essential for T cell antigen receptor-induced proliferation
Srividya Sriskantharajah et al.
NATURE IMMUNOLOGY (2009)
Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients
Barbara Cassani et al.
BLOOD (2008)
Compromised CD4(+) CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level
Koen Venken et al.
IMMUNOLOGY (2008)
Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells
Li Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Arginine methylation at a glance
Mark T. Bedford
JOURNAL OF CELL SCIENCE (2007)
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kebir et al.
NATURE MEDICINE (2007)
Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma
Sharmistha Pal et al.
EMBO JOURNAL (2007)
Quantitative network signal combinations downstream of TCR activation can predict IL-2 production response
Melissa L. Kemp et al.
JOURNAL OF IMMUNOLOGY (2007)
Effect of glatiramer acetate (Copaxone®) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis:: A longitudinal study
Y. Blanco et al.
NEUROSCIENCE LETTERS (2006)
Methylthioadenosine reverses brain autoimmune disease
Beatriz Moreno et al.
ANNALS OF NEUROLOGY (2006)
Medical progress: Multiple sclerosis - The plaque and its pathogenesis
EM Frohman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The activation of memory CD4+ T cells and CD8+ T cells in patients with multiple sclerosis
Y Okuda et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
CD28 costimulatory signal induces protein arginine methylation in T cells
F Blanchet et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Arginine methylation regulates IL-2 gene expression:: a role for protein arginine methyltransferase 5 (PRMT5)
S Richard et al.
BIOCHEMICAL JOURNAL (2005)
CD4 T cell activation and disease activity at onset of multiple sclerosis
J Jensen et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes
S Pal et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Multiple sclerosis:: a study of chemokine receptors and regulatory T cells in relation to MRI variables
P Putheti et al.
EUROPEAN JOURNAL OF NEUROLOGY (2003)
Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis
SJ Khoury et al.
ARCHIVES OF NEUROLOGY (2000)
Share Paper
